Medication info
Dispogen 5/80mg

Dispogen 5/80mg

Prescription medicationTabletOral
Ingredient · strength
Valsartan›80mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tablet
Manufacturer / importer
Dasan Pharmaceutical Co., Ltd.
Appearance
Dark yellow round film-coated tablet
Packaging
PTP - 28 tablets/box[(14 tablets/PTP package × 2)], bottle - 30 tablets/bottle
Approval status
Active

MFDS item code 201309049 · Approved 2013.08.29 · Insurance code 678600230

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, regardless of meals. It is recommended that the medication be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or valsartan) before starting this medication. However, if blood pressure is not adequately controlled with monotherapy using either component, switching directly to this medication may be considered as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medication (a combination product containing the same amount of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medication should not be used in patients with severe renal impairment (creatinine clearance less than 10mL/min) or in patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medication to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Adults 65 years of age or older: Use caution when increasing the dose.
Child dose
The safety and efficacy of this medication have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Ingredients

Manufacturer
Dasan Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This will explain the situation where a patient's essential hypertension is not sufficiently controlled by monotherapy with amlodipine or valsartan. In such cases, combining the two medications can lower blood pressure more effectively. Amlodipine works by widening blood vessels to improve blood flow, while valsartan counteracts substances that raise blood pressure, thereby lowering it. When monotherapy is ineffective, combination therapy provides better results in blood pressure control. Therefore, this medication is used to effectively control blood pressure in patients with essential hypertension.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, regardless of meals. It is recommended that the medication be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or valsartan) before starting this medication. However, if blood pressure is not adequately controlled with monotherapy using either component, switching directly to this medication may be considered as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medication (a combination product containing the same amount of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medication should not be used in patients with severe renal impairment (creatinine clearance less than 10mL/min) or in patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medication to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Adults 65 years of age or older: Use caution when increasing the dose.

Child dose

The safety and efficacy of this medication have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. This medication is contraindicated in patients who are allergic to the main ingredient or similar drugs, pregnant or breastfeeding women, patients with severe kidney or liver disease, and those with specific heart diseases. In patients with low sodium or fluid, hypotension may occur, so it is important to check their condition before taking the medication, and immediate treatment is required if symptoms of hypotension appear during treatment. Patients with high potassium levels or those taking potassium-sparing diuretics should have their potassium levels monitored frequently. Patients with problems in renal vessels or those who have recently undergone kidney transplantation should be cautious as taking this medication may worsen kidney function. Angioedema, which is swelling in the face or neck area, may occur, so if this symptom appears, the medication should be discontinued immediately. Patients with heart failure or those who have had a myocardial infarction should pay attention to changes in kidney function and hypotension when taking this medication, and regularly check their condition as directed by a physician. When taking this medication, dizziness or fatigue may occur, so caution is advised when driving or operating machinery. There may be interactions when taken with other antihypertensive medications, potassium-sparing diuretics, and certain anti-inflammatory drugs, so consultation with a doctor is necessary. Pregnant women or those planning to become pregnant should not use this medication, and breastfeeding women should also avoid it. The safety and efficacy of this medication in children under 18 years of age have not been established, so it is not recommended to administer it. In case of overdose, severe hypotension or heart problems may occur, so immediate emergency treatment should be sought. While taking this medication, blood pressure, kidney function, and electrolyte levels should be regularly monitored, and if any abnormal symptoms appear, medical consultation should be sought immediately.

Side effects

Nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, sore throat and larynx, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, rash, itching, joint swelling, low back pain, arthritis, muscle cramps, lethargy, polyuria, nocturia, erectile dysfunction, edema, periorbital edema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, elevated serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney injury, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reactions, hyperglycemia, insomnia, mood changes, tremors, hypesthesia, taste disturbances, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, phototoxic reactions, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorders, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, throat pain, hypercholesterolemia, hypoglycemia, neuroexcitation, hypesthesia, Stevens-Johnson syndrome, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. It is best to keep it at room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Dark yellow round film-coated tablet

Package unit

PTP - 28 tablets/box[(14 tablets/PTP package × 2)], bottle - 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.